Searchable abstracts of presentations at key conferences in endocrinology

ea0094p85 | Neuroendocrinology and Pituitary | SFEBES2023

Development of an optimal imaging pathway for management of somatotroph tumors in acromegaly

Haberbosch Linus , Macfarlane James , Koulouri Olympia , Gillett Dan , Spranger Joachim , Mai Knut , Cheow Heok , Jones Jonathan , Strasburger Christian , Gurnell Mark

Background: Acromegaly is associated with significant excess morbidity and mortality. Surgery and radiotherapy (including radiosurgery) aim to reduce the burden of growth hormone excess while preserving normal pituitary function, but their effective deployment is dependent on high quality imaging that allows accurate localization of site(s) of active de novo or residual/recurrent disease. Despite the existence of several comprehensive guidelines on the managem...

ea0077op2.1 | Adrenal and Cardiovascular | SFEBES2021

A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism

Senanayake Russell , Gillett Daniel , Bashari Waiel , MacFarlane James , Hu Lihua , Palma August , Aloj Luigi , Mendichovszky Iosif , Hader Stefan , Boros Istvan , Brown Morris , Cheow Heok , Aigbirhio Franklin , Gurnell Mark

Background: Primary aldosteronism (PA) is an important, potentially curable, cause of hypertension. Distinguishing unilateral and bilateral causes is a critical step in determining who should be considered for adrenalectomy. Adrenal vein sampling (AVS) remains the gold standard for lateralisation. However, AVS is technically challenging with limited availability. To address this, we have introduced molecular imaging using PET/CT with the radiotracer [11C]Metomidate ...

ea0077op3.3 | Reproductive and Neuroendocrinology | SFEBES2021

‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas

MacFarlane James , Kourlouri Olympia , Gillett Daniel , Senanayake Russell , Santarius Thomas , Tysome James , Donnelly Neil , Mendichovszky Iosif , Cheow Heok , Mannion Richard , Bashari Waiel , Gurnell Mark

Background: In a sub-group of patients with newly diagnosed pituitary adenomas, conventional MRI will fail to confidently localise the tumour. The role of molecular imaging for these patients is increasingly being recognised, both in terms of confirming diagnosis and in guiding targeted therapy; 11C-Methionine PET co-registered with volumetric MRI (Met-PET/MRCR) can enhance decision making in this group of patients. However, in some cases distinguishing t...

ea0081p263 | Adrenal and Cardiovascular Endocrinology | ECE2022

Development of a novel treatment strategy which involves thermal ablation of adrenal adenomas using electromagnetic energy

Farnan Richard , Bottiglieri Anna , Farina Laura , Senanayake Russell , Gurnell Mark , Prakash Punit , O'Halloran Martin , Cappiello Grazia , Newell Caoimhe , Keating Muireann , Rahmani George , Conall Dennedy Michael

Primary aldosteronism (PA) arises from one or both adrenal glands and is a common cause of secondary hypertension accounting for approximately 5-12% of all hypertension. Current therapy involves mineralocorticoid receptor antagonists for bilateral disease (60%) or adrenalectomy for unilateral disease (30%). We investigate treatment planning of percutaneous adrenal ablation as an alternative definitive therapeutic modality for unilateral and bilateral disease. The main objectiv...

ea0050cc06 | Featured Clinical Cases | SFEBES2017

Activating mutation in the arginine vasopressin receptor AVPR2 resulting in nephrogenic syndrome of inappropriate antidiuresis in a female

Majeed Mohamed Ashif , Hague Jennifer , Powlson Andrew S , Hale Julia , Casey Ruth , Oddy Sue , Gurnell Mark , Park Soo-Mi , Simpson Helen

Introduction: Hyponatraemia is the commonest electrolyte disturbance, but is not common in young people. Here, we describe a female subject, with recurrent unexplained symptomatic hyponatraemia in whom we considered the possibility of an activating mutation in the arginine vasopressin receptor type 2 (AVPR2) as a rare cause of Syndrome of Inappropriate Anti-Diuresis (SIAD).Case: A 39 year old woman had a history of unexplained hyponatraemia (serum sodium...

ea0050cc06 | Featured Clinical Cases | SFEBES2017

Activating mutation in the arginine vasopressin receptor AVPR2 resulting in nephrogenic syndrome of inappropriate antidiuresis in a female

Majeed Mohamed Ashif , Hague Jennifer , Powlson Andrew S , Hale Julia , Casey Ruth , Oddy Sue , Gurnell Mark , Park Soo-Mi , Simpson Helen

Introduction: Hyponatraemia is the commonest electrolyte disturbance, but is not common in young people. Here, we describe a female subject, with recurrent unexplained symptomatic hyponatraemia in whom we considered the possibility of an activating mutation in the arginine vasopressin receptor type 2 (AVPR2) as a rare cause of Syndrome of Inappropriate Anti-Diuresis (SIAD).Case: A 39 year old woman had a history of unexplained hyponatraemia (serum sodium...

ea0082p25 | Poster Presentations | SFEEU2022

An exception to the rule: transformation of an adrenocortical lesion with benign radiological characteristics

MacFarlane James , Lau Eunice , Palma August , Koulouri Olympia , Harper Ines , Stokes Victoria , Challis Ben , Shaw Ashley , Aloj Luigi , Mendichovszky Iosif , Cheow Heok , Bashari Waiel , Gurnell Mark , Casey Ruth

Section 1: Case history: A 69 year old man with chronic obstructive pulmonary disease was admitted with acute onset shortness of breath. A CT pulmonary angiogram revealed no focal lung abnormality but identified an incidental 40 x 32 mm left-sided adrenal lesion. An unenhanced CT, undertaken to characterise the lesion, showed a homogeneous, well-circumscribed appearance with a radiodensity of 4 Hounsfield units. Prior to involvement of the Endocrinology team, a dedicated MRI w...

ea0086oc3.1 | Reproductive and Neuroendocrinology | SFEBES2022

Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET

Koulouri Olympia , MacFarlane James , Bashari Waiel , Gillett Daniel , Senanayake Russell , Halsall David , Oddy Sue , Powlson Andrew , Serban Laura , Moran Carla , Schoenmakers Nadia , Chatterjee Krishna , Gurnell Mark

Context: Surgery is the first-line treatment option for thyrotropinomas, but medical therapy with somatostatin receptor ligands (SRL) may be used as neoadjuvant treatment and to facilitate safe surgery.Objectives: To determine the extent to which neoadjuvant SRL (i) corrects clinical, laboratory and tissue hyperthyroidism in thyrotropinomas, (ii) induces tumour shrinkage in macroadenomas, and (iii) aids microadenoma detection by 11C-methionine...

ea0065op6.1 | Neuroendocrinology, Pituitary and Neoplasia | SFEBES2019

Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease

Bashari Waiel A , Senanayake Russell , Fernandez-Pombo Antia , Gillett Daniel , Koulouri Olympia , Powlson Andrew , Cheow Heok , Mendichovszky Iosif , Kolias Angelos , Tysome James , Santarius Thomas , Mannion Richard , Gurnell Mark

Objective: To determine if an extended lateral approach to trans-sphenoidal surgery (TSS), guided by 11C-Methionine PET/CT co-registered with volumetric MRI (Met-PET/MRCR), can lead to remission in patients with persistent acromegaly due to post-operative lateral/para-sellar tumour remnants.Methods: We identified eight patients with persistent acromegaly following primary intervention [TSS ± medical therapy ± radiotherapy ...

ea0049gp27 | Adrenal 3 | ECE2017

The role of in vivo metabolomics using H-MRS in SDH deficient disease

Casey Ruth , McLean Mary , Bassetti Madhu , Challis Ben , Simpson Helen , Gurnell Mark , Bulusu Ramesh , Marker Alison , Giger Olivier , Allinson Kieran , Chatterjee Krishna , Maher Eamonn , Gallagher Ferdia

Tumours caused by mutations in the SDH enzyme complex have a unique tumour metabolome due to a truncated citric acid cycle. The accumulation of the onco-metabolite succinate is believed to drive tumourigenesis. The aim was to investigate the role of MRI spectroscopy (H-MRS) to detect in vivo succinate elevations in suspected SDH deficient tumours including GIST, phaeochromocytoma/paraganglioma (PPGL) and pituitary adenomas (PA). Suitable patients were identified based...